Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials.

Edwards, Jarem; Tasker, Annie; Pires da Silva, Inês; Quek, Camelia; Batten, Marcel; Ferguson, Angela; Allen, Ruth; Allanson, Benjamin; Saw, Robyn P M; Thompson, John F; Menzies, Alexander M; Palendira, Umaimainthan; Wilmott, James S; Long, Georgina V; Scolyer, Richard A.
Clin Cancer Res; 25(11): 3247-3258, 2019 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-30777877